Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

NLM Logo

aildenafil MeSH Supplementary Concept Data 2025


MeSH Supplementary
aildenafil
Unique ID
C520604
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/C520604
Entry Term(s)
1-((3-(6,7-dihydro-1-methyl-7-oxo-3-propyl-1H-pyrazolo(4,3-d)pyrimidin-5-yl)-4 -ethoxyphenyl)sulfonyl)-cis-3,5-dimethylpiperazine
Pharm Action
Phosphodiesterase 5 Inhibitors
Registry Numbers
9T49W8GAX6
CAS Type 1 Name
7H-Pyrazolo(4,3-d)pyrimidin-7-one, 5-(5-(((3R,5S)-3,5-dimethyl-1-piperazinyl)sulfonyl)-2-ethoxyphenyl)-1,4-dihydro-1-methyl-3-propyl-
Heading Mapped to
*Piperazines
*Sulfones
Frequency
9
Note
structure in first source
Source
J Pharm Biomed Anal 2007 May 9;44(1):231-5
Date of Entry
2007/06/21
Revision Date
2017/11/03
aildenafil Preferred
1-((3-(6,7-dihydro-1-methyl-7-oxo-3-propyl-1H-pyrazolo(4,3-d)pyrimidin-5-yl)-4 -ethoxyphenyl)sulfonyl)-cis-3,5-dimethylpiperazine Related
page delivered in 0.005s